169 filings
Page 5 of 9
8-K
l8l w4xyslqi4
10 Aug 22
Harpoon Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:14pm
8-K
8uwlxohmka7g n64nn
28 Jun 22
Departure of Directors or Certain Officers
4:02pm
8-K
fpjvpe0kccw99r3k g8d
3 Jun 22
Regulation FD Disclosure
5:05pm
8-K
xh6kmer g3m0
12 May 22
Harpoon Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:28pm
DEFA14A
ca73q7qr
29 Apr 22
Additional proxy soliciting materials
4:08pm
8-K
edt2 db99
7 Apr 22
Departure of Directors or Certain Officers
4:16pm
S-8
gznrh92ke nu
10 Mar 22
Registration of securities for employees
5:14pm
8-K
8os7k6 0xe2n
10 Mar 22
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:16pm
8-K
cl6ou zhh4djvq5dwr
11 Jan 22
Other Events
6:16am
8-K
74gw0d0
13 Dec 21
Other Events
5:28pm
8-K
ncovlbtrtzvtv4q
10 Nov 21
Harpoon Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:41pm
8-K
poefh2 26md9py
26 Oct 21
Departure of Directors or Certain Officers
4:19pm
8-K
iow764yexjz
5 Aug 21
Harpoon Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:22pm
8-K
drpule
4 Jun 21
Harpoon Therapeutics Presents Updated Interim Clinical Data for the PSMA-targeting TriTACĀ® HPN424 at the 2021 ASCO Annual Meeting
4:40pm
8-K
26z48
6 May 21
Harpoon Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
5:00pm